Laboratory Equipment and Lab Product News

New bench-top clinical chemistry analyzer launched by EKF Diagnostics at AACC 2015

EKF Diagnostics

23/07/2015

The new Altair™ 240 fully automated, cost-effective platform designed with Stanbio Chemistry products in mind.Cardiff, UK – 23rd July 2015 – EKF Diagnostics, the global in vitro diagnostics company, announces the international launch of the Altair™ 240 clinical chemistry analyzer at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo in Atlanta, Ga, 26-30 July. This new bench-top platform represents...

EKF Diagnostics’ Quo-Lab HbA1c Analyzer Secures IFCC Certification

EKF Diagnostics

10/01/2014

Cardiff, UK – 9th January 2014 – EKF Diagnostics, a global diagnostics company, is pleased to announce that its Quo-Lab HbA1c point-of-care analyzer has successfully achieved International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) certification. The IFCC maintains the JCTLM (Joint Committee for Traceability in Laboratory Medicine) endorsed reference measurement procedure for HbA1c, accepted worldwide as the analytical control for...

EKF HbA1c Analyzer Assessment Success Presented at World Diabetes Congress

EKF Diagnostics

03/12/2013

Cardiff, UK – 3nd December 2013 – EKF Diagnostics, the global diagnostics business, announces the successful assessment of its Quo-Test and Quo-Lab point-of-care HbA1c analyzers within the College of Medicine, Swansea University. Dr Stephen Luzio, Associate Professor at the University, is giving a scientific poster presentation entitled ‘Assessment of two point-of-care analyzers for the determination of HbA1c’ at the World Diabetes Congress –...

EKF Launches POC Lactate Analyzer with Hematocrit Compensation

EKF Diagnostics

20/11/2013

Built-in hematocrit compensation delivers high accuracy lactate analysisCardiff, UK – 20th November 2013 – EKF Diagnostics, the global diagnostics business, announces the launch of the new version of its Lactate Scout+ analyzer. Initially developed to provide coaches and athletes with a precise and easy-to-use mobile lactate test, Lactate Scout’s additional features and functionality – including hematocrit compensation – now mean the device...

EKF Molecular Diagnostics Launches New PointMan™ DNA Enrichment Kits at AMP 2013

EKF Diagnostics

13/11/2013

Cardiff, UK – 13 November 2013 – EKF Diagnostics, the global diagnostics business, announces that EKF Molecular Diagnostics will launch four new PointMan™ DNA enrichment kits at the Association for Molecular Pathology Annual Meeting (AMP 2013), 14-16th November, Phoenix, AZ. The new kits for the Research Use Only market, with planned diagnostic registration in Europe in 2014, offer highly specific and ultra-sensitive enrichment of multiple mutations in...

Lactate Scout + handheld POC analyser for lactate measurement

EKF Diagnostics

07/11/2013

Cardiff, UK – 7th November 2013 – EKF Diagnostics, the global point-of-care diagnostics business, announces it will be premiering two novel diagnostic tests at Medica 2013, 20th to 23rd November, Düsseldorf, Germany. On Stand C70 in Hall 3, EKF will introduce an updated version of Lactate Scout+, a hand-held POC analyzer for the measurement of lactate. This third version of Lactate Scout+ features hematocrit compensation which uniquely ensures that results...

EKF Diagnostics launches ß-Hydroxybutyrate Strip Test at AACC 2013

EKF Diagnostics

30/07/2013

Cardiff, UK – 24th July 2013 – EKF Diagnostics, the global in vitro diagnostics business, announces the worldwide launch of the new STAT-Site M ß-HB, following successful CE marking. The new quantitative strip-based test for ß-Hydroxybutyrate (ß-HB) provides a quick and easy assessment of diabetic ketoacidosis (DKA), delivering results in less than 80 seconds. STAT-Site M ß-HB will be premiered at Booth #3614 at the American Association...

The new Quo-Lab HbA1c analyser from EKF Diagnostics

EKF Diagnostics

17/05/2013

EKF Diagnostics, worldwide manufacturer of point-of-care (POC) diagnostic tools, will be exhibiting its innovative range of analysers for use in the detection and management of diabetes, anaemia, lactate and kidney related diseases at Hospitalar 2013, Sao Paulo, Brazil (21-24 May). On display in Green Hall - L81 - Stand 14 will be the new Quo-Lab and Quo-Test glycated haemoglobin (HbA1c) analysers for near-patient measurement and monitoring of diabetes. HbA1c...

EKF Diagnostics Announces Milestone for Hemo Control Hemoglobin Analyzer

EKF Diagnostics

14/03/2013

Cardiff, UK – 14th March 2013 – EKF Diagnostics, worldwide manufacturer of point-of-care (POC) diagnostic equipment, today announces that the 33,333rd Hemo Control hemoglobin analyzer has been built at EKF’s manufacturing facility in Barleben, Germany. Providing lab quality results within 25 seconds for both hemoglobin and hematocrit from one simple test, and with a CV of <2%, this robust analyzer has gained professional approval globally since the...

The new Quo-Lab HbA1c analyser from EKF Diagnostics

EKF Diagnostics

17/12/2012

Cardiff, UK – 17th December 2012 – EKF Diagnostics, worldwide manufacturer of point-of-care (POC) diagnostic tools, will be exhibiting its innovative range of products for diabetes and ketosis testing at Arab Health 2013 (28 – 31st January). As the world's longest running healthcare exhibition and congress, it attracts healthcare professionals from around the world to the International Convention and Exhibition Centre in Dubai. This event will also see...